Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-24 @ 2:15 PM
NCT ID:
NCT02908295
Eligibility Criteria:
Inclusion Criteria:
* Patient provisionally diagnosed with leiomyoma of uterus with less than 10 cm diameter
* Patient undergoing myomectomy, both open and laparoscopic approach
* Patient aged 25 - 50 years
* Patient able to give free and informed consent and who agrees to participate bu signing the consent form
* Patient able to speak and understand Thai
* Patient able to complete the questionnaire
Exclusion Criteria:
* Patient who was pathologically diagnosed apart from leiomyoma
* Patient with leiomyoma FIGO type 0
* Patient who has medical conditions that increase bleeding tendency, such as thrombocytopenia, coagulopathy, renal insufficiency, uncontrolled diabetes mellitus, taking antiplatelets or anticoagulants less than 7 days prior the surgery
* Patient who takes prostaglandin analogs and/or antagonists (NSAIDS) less than 7 days prior the surgery.
* Patient who may take higher risks of misoprostol adverse effect such as hypertension, ischemic heart disease, glaucoma, asthma
* Patient who had and allergic reaction to misoprostol or vitamin B6
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
25 Years
Maximum Age:
50 Years
Study:
NCT02908295
Study Brief:
Protocol Section:
NCT02908295